Administration of anticholinesterase drugs in the presence of beta-adrenergic blockade.
D000319:Adrenergic beta-Antagonists / Q000633:toxicity*; D000818:Animals; D001285:Atropine / Q000633:toxicity; D002800:Cholinesterase Inhibitors / Q000633:toxicity*; D004285:Dogs; D004357:Drug Synergism; D006339:Heart Rate / Q000187:drug effects*; D009388:Neostigmine / Q000633:toxicity; D010197:Pancuronium; D011433:Propranolol / Q000633:toxicity; D011729:Pyridostigmine Bromide / Q000633:toxicity
D000319:Adrenergic beta-Antagonists; D002800:Cholinesterase Inhibitors; D009388:Neostigmine; D001285:Atropine; D011433:Propranolol; D010197:Pancuronium; D011729:Pyridostigmine Bromide